Open AccessSilymarin: An option to treat non-alcoholic fatty liver disease
Author(s) -
Carmela Colica,
Luigi Boccuto,
Ludovico Abenavoli
Publication year - 2017
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v23.i47.8437
Subject(s) - fatty liver , alcoholic liver disease , medicine , overweight , gastroenterology , disease , alcoholic fatty liver , lipid metabolism , obesity , cirrhosis
We have read with a great interest the review published by Singh et al, on the treatment options in alcoholic and non-alcoholic fatty liver disease, including various new targeted therapies that are currently under investigation. Recently, we described the health effects of the Mediterranean diet associated to an antioxidant complex rich in silymarin, to improve in overweight patients anthropometric parameters, glucose and lipid metabolism and intra-hepatic fat accumulation.